ONL Therapeutics: Funding, Investors & Team (Sep 2026)
ONL Therapeutics is a biopharmaceutical company committed to preserving vision by safeguarding photoreceptors. Established in 2011, the company is based in Ann Arbor, Michigan.
ONL Therapeutics has raised $65.0M across 1 funding round on record, the most recent a Series D of $65.0M announced in Sep 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ONL Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
ONL Therapeutics Funding Rounds
ONL Therapeutics Founders and Leadership Team
Contact details for the ONL Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →ONL Therapeutics Funding Compared to Other Biotechnology Startups
ONL Therapeutics' latest round of $65.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ONL Therapeutics in Biotechnology and Ann Arbor
Companies Similar to ONL Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
ONL Therapeutics Funding FAQs
What does ONL Therapeutics do?
ONL Therapeutics is a biopharmaceutical company committed to preserving vision by safeguarding photoreceptors. Established in 2011, the company is based in Ann Arbor, Michigan.
How much funding has ONL Therapeutics raised?
ONL Therapeutics has raised $65.0M across 1 round on record. The most recent is a Series D of $65.0M announced in Sep 2024.
When did ONL Therapeutics last raise funding?
ONL Therapeutics' most recent funding round on record is a Series D of $65.0M, announced in Sep 2024.
Who founded ONL Therapeutics?
FundedIQ lists David Zacks (Founder) at ONL Therapeutics.
Where is ONL Therapeutics headquartered?
ONL Therapeutics is based in Ann Arbor, Michigan, United States.
How many employees does ONL Therapeutics have?
ONL Therapeutics is in the 11-50 employee band.
How does ONL Therapeutics' funding compare to other Biotechnology startups?
ONL Therapeutics' latest round of $65.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ONL Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ONL Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.